Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Undercarboxylated/uncarboxylated osteocalcin increases beta-cell proliferation, insulin secretion, insulin sensitivity, glucose tolerance and decreases fat mass

Undercarboxylated/uncarboxylated osteocalcin increases beta-cell proliferation, insulin secretion, insulin sensitivity, glucose tolerance and decreases fat mass

US Patent 9746463 · Granted Aug 29, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Cytokine-bisphosphonate conjugates2025
Methods, compositions and uses thereof for reversing sarcopenia2025
Osteocalcin as a treatment for frailty associated with aging2021
Osteocalcin as a treatment for cognitive disorders2018
Methods for identifying or assaying for agents that increase beta-cell prolifera2016
Methods for identifying or assaying for agents that increase beta-cell prolifera2016
Methods of preventing and treating diabetes by inhibiting serotonin synthesis2015
Osteocalcin as a treatment for male reproductive disorders2014
Osteocalcin as a treatment for male reproductive disorders2014
Methods of treating bone mass diseases2014
Methods of treating bone mass diseases2014
Methods of preventing and treating low bone mass diseases2013